chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, Dyspnoea, Erythema, Feeling hot, Headache
Clinical narrative: feeling nauseated, hot; feeling nauseated, hot; headache; difficulty breathing; itchy all over the body, with redness and blotchiness in the face, neck and arms; itchy all over the body, with redness and blotchiness in the face, neck and arms; itchy all over the body, with redness and blotchiness in the face, neck and arms; Blood pressure elevated along with heart rate.; Blood pressure elevated along with heart rate.; This is a spontaneous report from a contactable other healthcare professional (HCP), who is also the patient.  This 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 19Dec2020 at single dose for COVID-19 immunisation. Vaccination facility type was hospital. Relevant medical history included polycystic ovaries, gastrooesophageal reflux disease, Hashimoto's disease and allergy to sulfa, penicillin, latex and hornets. Concomitant medications included thyroid (ARMOUR THYROID), omeprazole and vitamin D3. On 19Dec2020 at 12:15, 10 minutes after the injection, the patient started feeling nauseated, hot and developed a headache. A couple of minutes after that, she started experiencing difficulty breathing and itchy all over the body, with redness and blotchiness in the face, neck and arms and blood pressure elevated along with heart rate. The events resulted in emergency room/department visit or urgent care. Corrective treatments taken as a result of the events included methylprednisolone sodium succinate (Solu-medrol), diphenhydramine hydrochloride (BENADRYL) and famotadine along with intravenous (IV) fluids. The patient recovered with sequel from the events on an unspecified date.  The information on the lot/ batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Heart rate increased, Nausea, Pruritus, Rash macular
Clinical narrative: feeling nauseated, hot; feeling nauseated, hot; headache; difficulty breathing; itchy all over the body, with redness and blotchiness in the face, neck and arms; itchy all over the body, with redness and blotchiness in the face, neck and arms; itchy all over the body, with redness and blotchiness in the face, neck and arms; Blood pressure elevated along with heart rate.; Blood pressure elevated along with heart rate.; This is a spontaneous report from a contactable other healthcare professional (HCP), who is also the patient.  This 34-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 19Dec2020 at single dose for COVID-19 immunisation. Vaccination facility type was hospital. Relevant medical history included polycystic ovaries, gastrooesophageal reflux disease, Hashimoto's disease and allergy to sulfa, penicillin, latex and hornets. Concomitant medications included thyroid (ARMOUR THYROID), omeprazole and vitamin D3. On 19Dec2020 at 12:15, 10 minutes after the injection, the patient started feeling nauseated, hot and developed a headache. A couple of minutes after that, she started experiencing difficulty breathing and itchy all over the body, with redness and blotchiness in the face, neck and arms and blood pressure elevated along with heart rate. The events resulted in emergency room/department visit or urgent care. Corrective treatments taken as a result of the events included methylprednisolone sodium succinate (Solu-medrol), diphenhydramine hydrochloride (BENADRYL) and famotadine along with intravenous (IV) fluids. The patient recovered with sequel from the events on an unspecified date.  The information on the lot/ batch number has been requested.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Chapped lips, Diarrhoea, Dysgeusia, Ear pain
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Fatigue, Headache, Hyposmia, Lip blister
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mouth ulceration, Myalgia, Nausea, Parosmia, Pharyngitis
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Photophobia, Sensitive skin, Skin lesion, Skin ulcer, Swelling
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face, Taste disorder
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Ear pain, Eye pain, Fatigue, Headache
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperaesthesia, Hyperhidrosis, Lip blister, Lymphadenopathy, Myalgia
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oral disorder, Oral mucosal blistering, Pharyngitis, Photophobia
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Stomatitis
Clinical narrative: Severe headache; photophobia; eye pain; myalgia; diarrhea; skin sensitivity; lesions and blisters around mouth and lips, oral lesions; lesions and blisters around mouth and lips, oral lesions/intra-oral lesions/Buccal lesion; inflammation; pharyngitis; lymph node inflammation in neck; BL earache; nausea; diaphoresis; fatigue; This is a spontaneous report from a contactable consumer (patient). A 50-years-old female patient received first dose of BNT162B2 (Lot# EH9899), via an unspecified route of administration, in right arm, on 18Dec2020 15:00 at single dose for COVID -19 immunization. The patient was not pregnant at the time of vaccination. Facility where the most recent COVID-19 vaccine was administered was workplace clinic. Medical history was none, good health. No allergies to medications, food, or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. No other vaccines was received within 4 weeks prior to the COVID vaccine. The other medication that the patient received within 2 weeks of vaccination was amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) at 30 mg orally daily. The patient experienced severe headache, photophobia and eye pain, myalgia, diarrhea, skin sensitivity, lesions and blisters around mouth and lips, oral lesions and inflammation, intra-oral lesions, buccal lesions, pharyngitis, lymph node inflammation in neck, BL earache, nausea, diaphoresis, fatigue, all on 19Dec2020 05:00 AM. The events were reported as non-serious. No treatment was received for the events. The outcome of the events was recovering.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Joint swelling, Pruritus
Clinical narrative: redness and swelling to right wrist; redness and swelling to right wrist; Itching to left side neck and back.; This is a spontaneous report from a contactable nurse. A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EJ1685, first dose via intramuscular in left arm on 21Dec2020 09:30 at SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced redness and swelling to right wrist and itching to left side neck and back on 21Dec2020 09:45. The facility where the most recent COVID-19 vaccine was administered was in the hospital. The events resulted in emergency room or department or urgent care. The case was reported as non serious by the reporter, and did not result in death, not life threatening, did not cause prolonged hospitalization, not disabling or incapacitating and no congenital anomaly or birth defect. The outcome of the events was unknown.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Palpitations
Clinical narrative: Heart palpitations and severe fatigue for 48 hours; Heart palpitations and severe fatigue for 48 hours; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 37-year-old female patient received bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot EK5730), intramuscularly in the left arm on 18Dec2020 10:30 at single dose (dose number 1) for immunisation. Medical history was none. There were no concomitant medications. The patient experienced heart palpitations and severe fatigue for 48 hours on 18Dec2020 18:00. The events were reported as non-serious. No treatment was given. The outcome of events was recovered on unknown date in Dec2020.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Muscular weakness, Paraesthesia
Clinical narrative: parasthesia in injected arm including ring and pinky fingers; parasthesia in injected arm including ring and pinky fingers; weakness in injection arm up to the tricep muscle; He also experienced mild weakness; This is a spontaneous report from a contactable nurse (patient). A 33-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5930), via an unspecified route of administration in left arm on 21Dec2020 09:00 at a single dose in TB size syringe for COVID-19 immunization. The patient has no medical history. There were no concomitant medications. The patient is a nurse anesthetist calling about himself, stating that he thinks he has had a reaction to the Pfizer COVID Vaccine. He took a dose about 9am this morning and about 2.5 hours later he experienced paresthesia in his injected arm including his ring and pinky fingers. He also experienced mild weakness. The symptoms lasted about 45 minutes. Stated that the symptoms lasted about 45 minutes and has completely resolved thus far; however, he cannot attest if these symptoms will return or not. Stated that it was given with a TB size syringe and so assumes that it was the standard dose that he received, but does not know for sure. No treatment was received for the symptoms. He just monitored himself. Caller wants to know if he should move forward with the second dose. He heard about Bells Palsy. If he had paresthesia with his first dose in the injected arm, could the paresthesia come to his face next? He wants to know if he is in the normal category to advance with the second dose. The events were reported as not serious. The events recovered on 21Dec2020.
Age: 33.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Paraesthesia
Clinical narrative: parasthesia in injected arm including ring and pinky fingers; parasthesia in injected arm including ring and pinky fingers; weakness in injection arm up to the tricep muscle; He also experienced mild weakness; This is a spontaneous report from a contactable nurse (patient). A 33-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5930), via an unspecified route of administration in left arm on 21Dec2020 09:00 at a single dose in TB size syringe for COVID-19 immunization. The patient has no medical history. There were no concomitant medications. The patient is a nurse anesthetist calling about himself, stating that he thinks he has had a reaction to the Pfizer COVID Vaccine. He took a dose about 9am this morning and about 2.5 hours later he experienced paresthesia in his injected arm including his ring and pinky fingers. He also experienced mild weakness. The symptoms lasted about 45 minutes. Stated that the symptoms lasted about 45 minutes and has completely resolved thus far; however, he cannot attest if these symptoms will return or not. Stated that it was given with a TB size syringe and so assumes that it was the standard dose that he received, but does not know for sure. No treatment was received for the symptoms. He just monitored himself. Caller wants to know if he should move forward with the second dose. He heard about Bells Palsy. If he had paresthesia with his first dose in the injected arm, could the paresthesia come to his face next? He wants to know if he is in the normal category to advance with the second dose. The events were reported as not serious. The events recovered on 21Dec2020.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Muscle spasms, Myalgia, Pyrexia
Clinical narrative: Woke up in middle of night; severe muscle pain entire body; chills/fever; chills/fever; debilitating headache; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, intramuscular (left arm) on 20Dec2020 10:00 at a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ), metoprolol succinate (METOPROLOL SUCCINATE), and estrogens conjugated (PREMARIN). The patient reported she woke up in middle of night, had severe muscle pain on entire body, chills/fever, and debilitating headache on 21Dec2020 02:00. No treatment was received. The events were reported as non-serious. The patient was not pregnant. The patient has not been diagnosed of Covid-19 prior to vaccination and has not been tested. Outcome of the events was recovering.  Information about lot/batch no has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder
Clinical narrative: Woke up in middle of night; severe muscle pain entire body; chills/fever; chills/fever; debilitating headache; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, intramuscular (left arm) on 20Dec2020 10:00 at a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ), metoprolol succinate (METOPROLOL SUCCINATE), and estrogens conjugated (PREMARIN). The patient reported she woke up in middle of night, had severe muscle pain on entire body, chills/fever, and debilitating headache on 21Dec2020 02:00. No treatment was received. The events were reported as non-serious. The patient was not pregnant. The patient has not been diagnosed of Covid-19 prior to vaccination and has not been tested. Outcome of the events was recovering.  Information about lot/batch no has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Myalgia, Pyrexia, Sleep disorder
Clinical narrative: Woke up in middle of night; severe muscle pain entire body; chills/fever; chills/fever; debilitating headache; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, intramuscular (left arm) on 20Dec2020 10:00 at a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]), hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ), metoprolol succinate (METOPROLOL SUCCINATE), and estrogens conjugated (PREMARIN). The patient reported she woke up in middle of night, had severe muscle pain on entire body, chills/fever, and debilitating headache on 21Dec2020 02:00. No treatment was received. The events were reported as non-serious. The patient was not pregnant. The patient has not been diagnosed of Covid-19 prior to vaccination and has not been tested. Outcome of the events was recovering.  Information about lot/batch no has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Pharyngeal paraesthesia, Rash macular
Clinical narrative: feeling light headed; blotchy spots on neck and chest; tingling to the back of the throat; This is a spontaneous report from a contactable nurse. A 42-year-old female patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) intramuscular on left arm on 21Dec2020 10:15 AM, single dose for COVID-19 immunization at 42-year-old. Medical history and concomitant medication were not reported. On 21Dec2020 10:30 AM, the patient was reported feeling light-headed, blotchy spots on neck and chest, and tingling to the back of the throat. Emergency room/department or urgent care visited. Action taken for BNT162B2 was not applicable. Outcome of the events was unknown.  It was reported as non-serious.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Pharyngeal paraesthesia, Rash, Rash macular
Clinical narrative: feeling light headed; blotchy spots on neck and chest; tingling to the back of the throat; This is a spontaneous report from a contactable nurse. A 42-year-old female patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685) intramuscular on left arm on 21Dec2020 10:15 AM, single dose for COVID-19 immunization at 42-year-old. Medical history and concomitant medication were not reported. On 21Dec2020 10:30 AM, the patient was reported feeling light-headed, blotchy spots on neck and chest, and tingling to the back of the throat. Emergency room/department or urgent care visited. Action taken for BNT162B2 was not applicable. Outcome of the events was unknown.  It was reported as non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Peripheral swelling, Swelling face, Swelling of eyelid
Clinical narrative: swelling of eyelids and cheeks; swelling of eyelids and cheeks; swelling of hands; This is a spontaneous report from a contactable pharmacist. A 58-year-old female patient received 1 dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) intramuscular on left deltoid on 16Dec2020 11:00 AM, single dose for COVID-19 immunization at 58-year-old. Medical history included: Sulfa allergy; diabetes, hypertension, high cholesterol. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included: metformin, valsartan and pantoprazole. No other vaccine received within 4 weeks prior to the COVID vaccine. On 17Dec2020 morning, 06:00 AM, the patient had swelling of hands and then 18Dec2020 morning, the patient had swelling of eyelids and cheeks. Doctor or other healthcare professional office/clinic visit. Treatment received as: Diphenhydramine 50mg and prednisone 40mg orally. Since the vaccination, the patient had not been tested for COVID-19. Action taken for BNT162B2 was not applicable. Outcome of the events was resolved in Dec2020. It was reported as non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Hot flush, Oral discomfort, Oral pruritus, Paraesthesia oral
Clinical narrative: Got hot; flushed; weakness; few minutes of itchy throat and back; few minutes of itchy throat and back; lips tingling; a lump in the throat feeling; This is a spontaneous report from a contactable nurse (patient).  A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730), intramuscular on the left arm on 20Dec2020 12:00 at a single dose for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), attention deficit hyperactivity disorder (ADD), and lactose intolerance. Concomitant medications included hyoscyamine and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Dec2020 12:00, the patient experienced got hot, flushed, weakness, few minutes of itchy throat and back, lips tingling, and a lump in the throat feeling. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. The events were considered non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Sensation of foreign body, Throat irritation
Clinical narrative: Got hot; flushed; weakness; few minutes of itchy throat and back; few minutes of itchy throat and back; lips tingling; a lump in the throat feeling; This is a spontaneous report from a contactable nurse (patient).  A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730), intramuscular on the left arm on 20Dec2020 12:00 at a single dose for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), attention deficit hyperactivity disorder (ADD), and lactose intolerance. Concomitant medications included hyoscyamine and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Dec2020 12:00, the patient experienced got hot, flushed, weakness, few minutes of itchy throat and back, lips tingling, and a lump in the throat feeling. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. The events were considered non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Feeling hot, Flushing, Paraesthesia oral, Pruritus
Clinical narrative: Got hot; flushed; weakness; few minutes of itchy throat and back; few minutes of itchy throat and back; lips tingling; a lump in the throat feeling; This is a spontaneous report from a contactable nurse (patient).  A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730), intramuscular on the left arm on 20Dec2020 12:00 at a single dose for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), attention deficit hyperactivity disorder (ADD), and lactose intolerance. Concomitant medications included hyoscyamine and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Dec2020 12:00, the patient experienced got hot, flushed, weakness, few minutes of itchy throat and back, lips tingling, and a lump in the throat feeling. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. The events were considered non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Sensation of foreign body, Throat irritation
Clinical narrative: Got hot; flushed; weakness; few minutes of itchy throat and back; few minutes of itchy throat and back; lips tingling; a lump in the throat feeling; This is a spontaneous report from a contactable nurse (patient).  A 40-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730), intramuscular on the left arm on 20Dec2020 12:00 at a single dose for COVID-19 immunization. The patient's medical history included irritable bowel syndrome (IBS), attention deficit hyperactivity disorder (ADD), and lactose intolerance. Concomitant medications included hyoscyamine and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20Dec2020 12:00, the patient experienced got hot, flushed, weakness, few minutes of itchy throat and back, lips tingling, and a lump in the throat feeling. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering. The events were considered non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea
Clinical narrative: sore throat; runny nose; This is a spontaneous report from a contactable consumer (patient). A 20-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EL0140) via an unspecified route of administration on left arm on 18Dec2020 at single dose for COVID-19 vaccination. There was no medical history. There were no concomitant medications. The patient is asking if this is part of the documented side effects of the vaccine. She received the Covid19 vaccine last Friday (18Dec2020), at noon, the first in the series of two. She says on Saturday (19Dec2020) she woke up with a runny nose, and then on Sunday night (20Dec2020) she had a sore throat. She says she would like to know if her body fighting is fighting something off or building antibodies. She received the vaccine from work and it was optional, not prescribed. She has her vaccine card and all it has on the back is the name Pfizer and the LOT. She didn't take any new medications or receive any other injections at the time of the COVID-19 vaccine. She didn't do any treatments for the sore throat and runny nose. Events outcome was unknown.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Chills, Cough, Dyspnoea
Clinical narrative: Cough; Got a COVID test; positive; 4 hours after, my arm became sore; body aches; Still feel sick but not as sick as I was; shortness of breath; fever; Developed like pretty bad symptoms; This is a spontaneous report from a contactable nurse reported for himself. This 38-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at arm on 16Dec2020 at single dose (lot number: PAA156051) for vaccinated against COVID 19. Medical history included HIV. Concomitant medications included bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate (BIKTARVY) for HIV. The patient had received the Pfizer vaccine for COVID 19 on 16Dec2020 (Wednesday). And then the patient developed like pretty bad symptoms. Then, when the patient went to get tested because he suddenly started having like a cough at night on 16Dec2020 and got a COVID test and it was positive on Dec2020. The patient was a nurse in the emergency room and just wanted to report that. The patient knew scientifically it couldn't give him the virus. The patient didn't have any symptoms of COVID. So, after the patient got the shot, 4 hours after, his arm became sore and then 12 hours after, he had body aches, fever, cough, shortness of breath on Dec2020. About Lab Work, the patient stated, "Just the COVID one." And the patient got positive results for COVID test. Due date for the next shot was 06Jan2021. When asked if he was still experiencing cough, the patient stated he still felt sick but he was not as sick as he was. The first 2 or 3 days were really bad. About treatment, the patient stated, "Nothing for the cough but I took Tylenol." Outcome of the events was unknown.   Information about batch/lot number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling abnormal, Pain, SARS-CoV-2 test positive
Clinical narrative: Cough; Got a COVID test; positive; 4 hours after, my arm became sore; body aches; Still feel sick but not as sick as I was; shortness of breath; fever; Developed like pretty bad symptoms; This is a spontaneous report from a contactable nurse reported for himself. This 38-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at arm on 16Dec2020 at single dose (lot number: PAA156051) for vaccinated against COVID 19. Medical history included HIV. Concomitant medications included bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate (BIKTARVY) for HIV. The patient had received the Pfizer vaccine for COVID 19 on 16Dec2020 (Wednesday). And then the patient developed like pretty bad symptoms. Then, when the patient went to get tested because he suddenly started having like a cough at night on 16Dec2020 and got a COVID test and it was positive on Dec2020. The patient was a nurse in the emergency room and just wanted to report that. The patient knew scientifically it couldn't give him the virus. The patient didn't have any symptoms of COVID. So, after the patient got the shot, 4 hours after, his arm became sore and then 12 hours after, he had body aches, fever, cough, shortness of breath on Dec2020. About Lab Work, the patient stated, "Just the COVID one." And the patient got positive results for COVID test. Due date for the next shot was 06Jan2021. When asked if he was still experiencing cough, the patient stated he still felt sick but he was not as sick as he was. The first 2 or 3 days were really bad. About treatment, the patient stated, "Nothing for the cough but I took Tylenol." Outcome of the events was unknown.   Information about batch/lot number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Dyspnoea, Malaise, Pain, Pain in extremity
Clinical narrative: Cough; Got a COVID test; positive; 4 hours after, my arm became sore; body aches; Still feel sick but not as sick as I was; shortness of breath; fever; Developed like pretty bad symptoms; This is a spontaneous report from a contactable nurse reported for himself. This 38-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at arm on 16Dec2020 at single dose (lot number: PAA156051) for vaccinated against COVID 19. Medical history included HIV. Concomitant medications included bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate (BIKTARVY) for HIV. The patient had received the Pfizer vaccine for COVID 19 on 16Dec2020 (Wednesday). And then the patient developed like pretty bad symptoms. Then, when the patient went to get tested because he suddenly started having like a cough at night on 16Dec2020 and got a COVID test and it was positive on Dec2020. The patient was a nurse in the emergency room and just wanted to report that. The patient knew scientifically it couldn't give him the virus. The patient didn't have any symptoms of COVID. So, after the patient got the shot, 4 hours after, his arm became sore and then 12 hours after, he had body aches, fever, cough, shortness of breath on Dec2020. About Lab Work, the patient stated, "Just the COVID one." And the patient got positive results for COVID test. Due date for the next shot was 06Jan2021. When asked if he was still experiencing cough, the patient stated he still felt sick but he was not as sick as he was. The first 2 or 3 days were really bad. About treatment, the patient stated, "Nothing for the cough but I took Tylenol." Outcome of the events was unknown.   Information about batch/lot number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Cough; Got a COVID test; positive; 4 hours after, my arm became sore; body aches; Still feel sick but not as sick as I was; shortness of breath; fever; Developed like pretty bad symptoms; This is a spontaneous report from a contactable nurse reported for himself. This 38-year-old male patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at arm on 16Dec2020 at single dose (lot number: PAA156051) for vaccinated against COVID 19. Medical history included HIV. Concomitant medications included bictegravir sodium/emtricitabine/tenofovir alafenamide fumarate (BIKTARVY) for HIV. The patient had received the Pfizer vaccine for COVID 19 on 16Dec2020 (Wednesday). And then the patient developed like pretty bad symptoms. Then, when the patient went to get tested because he suddenly started having like a cough at night on 16Dec2020 and got a COVID test and it was positive on Dec2020. The patient was a nurse in the emergency room and just wanted to report that. The patient knew scientifically it couldn't give him the virus. The patient didn't have any symptoms of COVID. So, after the patient got the shot, 4 hours after, his arm became sore and then 12 hours after, he had body aches, fever, cough, shortness of breath on Dec2020. About Lab Work, the patient stated, "Just the COVID one." And the patient got positive results for COVID test. Due date for the next shot was 06Jan2021. When asked if he was still experiencing cough, the patient stated he still felt sick but he was not as sick as he was. The first 2 or 3 days were really bad. About treatment, the patient stated, "Nothing for the cough but I took Tylenol." Outcome of the events was unknown.   Information about batch/lot number has been requested.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose normal, Dizziness, Dysphagia, Hypoglycaemia, Somnolence
Clinical narrative: hypoglycemia; dizziness; This is a spontaneous report from a non-contactable Other HCP. A 33-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number HE9899, intramuscularly in the left arm on unspecified date at single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. The patient previously took spironolactone and experienced drug allergy. During her 15-minute waiting period after the vaccination, the patient began to experience feelings of hypoglycemia. She checked her blood glucose with her own monitor and had 77 at 11:04. She chewed 1 glucose tab that she had in her purse. She noted some difficulty with swallowing it and notified clinic staff. The patient also experienced dizziness and was escorted by clinic staff to the emergency bay. This provider was notified of patient reaction and she was then assessed in the emergency bay area. She denied difficulty breathing and chest pain, history of adverse reactions with prior vaccinations or allergies to medications with the exception of spironolactone. Patient had already been given a bottle of water by clinic staff and reported that the glucose tablet went down easier following the water. She took a second glucose tab sometime before 11:13. The event was assessed as non-serious. Outcome of the events hypoglycemia and dizziness was unknown.  No follow-up attempts are possible. No further information is expected.